These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
342 related articles for article (PubMed ID: 26188037)
1. Therapeutic drug monitoring of the β-lactam antibiotics: what is the evidence and which patients should we be using it for? Huttner A; Harbarth S; Hope WW; Lipman J; Roberts JA J Antimicrob Chemother; 2015 Dec; 70(12):3178-83. PubMed ID: 26188037 [TBL] [Abstract][Full Text] [Related]
2. Therapeutic drug monitoring of beta-lactam antibiotics in burns patients--a one-year prospective study. Patel BM; Paratz J; See NC; Muller MJ; Rudd M; Paterson D; Briscoe SE; Ungerer J; McWhinney BC; Lipman J; Roberts JA Ther Drug Monit; 2012 Apr; 34(2):160-4. PubMed ID: 22406650 [TBL] [Abstract][Full Text] [Related]
3. Impact of β-lactam antibiotic therapeutic drug monitoring on dose adjustments in critically ill patients undergoing continuous renal replacement therapy. Economou CJP; Wong G; McWhinney B; Ungerer JPJ; Lipman J; Roberts JA Int J Antimicrob Agents; 2017 May; 49(5):589-594. PubMed ID: 28341612 [TBL] [Abstract][Full Text] [Related]
4. β-Lactam therapeutic drug monitoring in the critically ill: optimising drug exposure in patients with fluctuating renal function and hypoalbuminaemia. Hayashi Y; Lipman J; Udy AA; Ng M; McWhinney B; Ungerer J; Lust K; Roberts JA Int J Antimicrob Agents; 2013 Feb; 41(2):162-6. PubMed ID: 23153962 [TBL] [Abstract][Full Text] [Related]
5. Prolonged administration of β-lactam antibiotics - a comprehensive review and critical appraisal. Osthoff M; Siegemund M; Balestra G; Abdul-Aziz MH; Roberts JA Swiss Med Wkly; 2016; 146():w14368. PubMed ID: 27731492 [TBL] [Abstract][Full Text] [Related]
6. An international, multicentre survey of β-lactam antibiotic therapeutic drug monitoring practice in intensive care units. Wong G; Brinkman A; Benefield RJ; Carlier M; De Waele JJ; El Helali N; Frey O; Harbarth S; Huttner A; McWhinney B; Misset B; Pea F; Preisenberger J; Roberts MS; Robertson TA; Roehr A; Sime FB; Taccone FS; Ungerer JP; Lipman J; Roberts JA J Antimicrob Chemother; 2014 May; 69(5):1416-23. PubMed ID: 24443514 [TBL] [Abstract][Full Text] [Related]
7. Therapeutic drug monitoring of β-lactam antibiotics in the critically ill: direct measurement of unbound drug concentrations to achieve appropriate drug exposures. Wong G; Briscoe S; McWhinney B; Ally M; Ungerer J; Lipman J; Roberts JA J Antimicrob Chemother; 2018 Nov; 73(11):3087-3094. PubMed ID: 30137377 [TBL] [Abstract][Full Text] [Related]
8. Therapeutic drug monitoring of beta-lactams in critically ill patients: proof of concept. Roberts JA; Ulldemolins M; Roberts MS; McWhinney B; Ungerer J; Paterson DL; Lipman J Int J Antimicrob Agents; 2010 Oct; 36(4):332-9. PubMed ID: 20685085 [TBL] [Abstract][Full Text] [Related]
9. Towards precision medicine: Therapeutic drug monitoring-guided dosing of vancomycin and β-lactam antibiotics to maximize effectiveness and minimize toxicity. Cusumano JA; Klinker KP; Huttner A; Luther MK; Roberts JA; LaPlante KL Am J Health Syst Pharm; 2020 Jul; 77(14):1104-1112. PubMed ID: 32537644 [TBL] [Abstract][Full Text] [Related]
10. Therapeutic Drug Monitoring of Beta-Lactams and Other Antibiotics in the Intensive Care Unit: Which Agents, Which Patients and Which Infections? Muller AE; Huttner B; Huttner A Drugs; 2018 Mar; 78(4):439-451. PubMed ID: 29476349 [TBL] [Abstract][Full Text] [Related]
11. Assays for therapeutic drug monitoring of β-lactam antibiotics: A structured review. Carlier M; Stove V; Wallis SC; De Waele JJ; Verstraete AG; Lipman J; Roberts JA Int J Antimicrob Agents; 2015 Oct; 46(4):367-75. PubMed ID: 26271599 [TBL] [Abstract][Full Text] [Related]
12. A guide to therapeutic drug monitoring of β-lactam antibiotics. Fratoni AJ; Nicolau DP; Kuti JL Pharmacotherapy; 2021 Feb; 41(2):220-233. PubMed ID: 33480024 [TBL] [Abstract][Full Text] [Related]
13. Failure of target attainment of beta-lactam antibiotics in critically ill patients and associated risk factors: a two-center prospective study (EXPAT). Abdulla A; Dijkstra A; Hunfeld NGM; Endeman H; Bahmany S; Ewoldt TMJ; Muller AE; van Gelder T; Gommers D; Koch BCP Crit Care; 2020 Sep; 24(1):558. PubMed ID: 32933574 [TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetic aspects of beta-lactam antibiotic therapy in intensive care unit patients: A one-center experience with TDM. Sadilová K; Halačová M; Černý D Ceska Slov Farm; 2020; 69(1):17-23. PubMed ID: 32460506 [TBL] [Abstract][Full Text] [Related]
15. Optimizing dosing of antibiotics in critically ill patients. Parker SL; Sime FB; Roberts JA Curr Opin Infect Dis; 2015 Dec; 28(6):497-504. PubMed ID: 26382000 [TBL] [Abstract][Full Text] [Related]
16. The clinical application of beta-lactam antibiotic therapeutic drug monitoring in the critical care setting. Pai Mangalore R; Peel TN; Udy AA; Peleg AY J Antimicrob Chemother; 2023 Oct; 78(10):2395-2405. PubMed ID: 37466209 [TBL] [Abstract][Full Text] [Related]
17. Implementation of a β-lactam therapeutic drug monitoring program: Experience from a large academic medical center. Venugopalan V; Hamza M; Santevecchi B; DeSear K; Cherabuddi K; Peloquin CA; Alshaer MH Am J Health Syst Pharm; 2022 Sep; 79(18):1586-1591. PubMed ID: 35704702 [TBL] [Abstract][Full Text] [Related]
18. Augmented renal clearance and therapeutic monitoring of β-lactams. Udy AA; De Waele JJ; Lipman J Int J Antimicrob Agents; 2015 Apr; 45(4):331-3. PubMed ID: 25665727 [TBL] [Abstract][Full Text] [Related]
19. Correlation of in vitro activity and pharmacokinetic parameters with effect in vivo for antibiotics. Observations from experimental pneumococcus infection. Frimodt-Møller N Dan Med Bull; 1988 Oct; 35(5):422-37. PubMed ID: 3066588 [TBL] [Abstract][Full Text] [Related]
20. Therapeutic drug monitoring of β-lactam antibiotics in the ICU. Dhaese S; Van Vooren S; Boelens J; De Waele J Expert Rev Anti Infect Ther; 2020 Nov; 18(11):1155-1164. PubMed ID: 32597263 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]